Symrise looks forward to in-cosmetics
This article was originally published in The Rose Sheet
Executive SummaryGerman raw materials supplier will unveil a slew of new offerings at the in-cosmetics exhibition April 13-15 in Paris, including SymPeptide 226EL, a cosmetic active "for long and beautiful eyelashes," and SymVital, designed "for efficient collagen enhancement to fight fine lines, wrinkles and sagging skin." SymDeo B125, a 24-hour deodorant with anti-biofilm properties, is backed by new findings suggesting effectiveness against foot odor, while SymSitive actives range offers fast relief for sensitive skin, according to April 6 release. SymMollient varieties L and S are new emollients that "significantly improve the skin's moisture content to make it radiant and smooth," firm says. Antioxidant Actipone Superfruits and Extrapone Gemstones, "a range of precious stones approved by Ecocert for natural and organic cosmetics," also will be on display
You may also be interested in...
The French drugmaker is paying $2.5bn to get hold of THOR-707 which it claims has the potential to become the best-in-class IL-2 therapeutic for solid tumors, thanks to improved pharmacology and less frequent dosing.
For the first time, a working group within the International Council for Harmonization has started work on a regulatory topic specifically tailored to the global generics and biosimilars industry.
In 2019, Mylan moved up to become the world’s leading generics, biosimilars and OTC player, according to Informa Pharma Intelligence’s latest global rankings. Sandoz has surpassed troubled Teva into second place but is set to surrender that position following the sale of its US solid-dose and dermatology business to India’s Aurobindo.